MCX Soars! UBS Upgrades to 'Buy' with Rs 3,800 Target Price
MCX Soars! UBS Upgrades to 'Buy' with Rs 3,800 Target Price
Big news for investors! UBS has upgraded MCX shares to a 'Buy' rating, setting an ambitious target price of Rs 3,800. Discover what's fueling this optimistic outlook and the potential catalysts ahead. #MCX #StockMarket
In a significant development for the Indian capital markets, global financial giant UBS has revised its rating for Multi Commodity Exchange of India Ltd (MCX) shares to a 'Buy' from its previous 'Neutral' stance. This upgrade comes with a substantially raised target price of Rs 3,800, signaling strong confidence in the commodity derivatives exchange's future performance.
UBS analysts highlighted several key factors driving this optimistic revision. Among them are attractive valuations of MCX, resilient trading volumes observed in recent periods, and positive regulatory developments that are expected to bolster growth. Notably, the brokerage pointed to the potential participation of Foreign Portfolio Investors (FPIs) in physically settled non-agricultural commodity derivatives and non-agricultural index derivatives as a crucial medium-term growth catalyst for MCX.
The investment firm has also increased its earnings per share (EPS) estimates for MCX for the financial years 2027 to 2029 by an impressive 4% to 9%. This upward revision is predicated on expectations of strong commodity volatility, which often drives trading activity on exchanges, and significant operating leverage that could support robust earnings growth for MCX in the coming years. The upgrade suggests a favorable outlook for investors looking at the commodity market space.
